Visually Interpretable Models of Kinase Selectivity Related Features Derived from Field-Based Proteochemometrics

Achieving selectivity for small organic molecules toward biological targets is a main focus of drug discovery but has been proven difficult, for example, for kinases because of the high similarity of their ATP binding pockets. To support the design of more selective inhibitors with fewer side effects or with altered target profiles for improved efficacy, we developed a method combining ligand- and receptor-based information. Conventional QSAR models enable one to study the interactions of multiple ligands toward a single protein target, but in order to understand the interactions between multiple ligands and multiple proteins, we have used proteochemometrics, a multivariate statistics method that aims to combine and correlate both ligand and protein descriptions with affinity to receptors. The superimposed binding sites of 50 unique kinases were described by molecular interaction fields derived from knowledge-based potentials and Schrödinger's WaterMap software. Eighty ligands were described by Mold(2), Open Babel, and Volsurf descriptors. Partial least-squares regression including cross-terms, which describe the selectivity, was used for model building. This combination of methods allows interpretation and easy visualization of the models within the context of ligand binding pockets, which can be translated readily into the design of novel inhibitors.

[1]  T. Lundstedt,et al.  PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. , 2001, Biochimica et biophysica acta.

[2]  Heng Tao Shen,et al.  Principal Component Analysis , 2009, Encyclopedia of Biometrics.

[3]  Peteris Prusis,et al.  Proteochemometric modeling of HIV protease susceptibility , 2008, BMC Bioinformatics.

[4]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[5]  Z. R. Li,et al.  Update of PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence , 2006, Nucleic Acids Res..

[6]  I. Melnikova,et al.  Targeting protein kinases , 2004, Nature Reviews Drug Discovery.

[7]  Woody Sherman,et al.  ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers , 2010, J. Chem. Inf. Model..

[8]  Erik Johansson,et al.  GIFI‐PLS: Modeling of Non‐Linearities and Discontinuities in QSAR , 2000 .

[9]  P. Prusis,et al.  Proteochemometric modelling of antibody-antigen interactions using SPOT synthesised peptide arrays. , 2007, Protein engineering, design & selection : PEDS.

[10]  Jarl E. S. Wikberg,et al.  Generalized Proteochemometric Model of Multiple Cytochrome P450 Enzymes and Their Inhibitors , 2008, J. Chem. Inf. Model..

[11]  L. Jiang,et al.  PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence , 2006, Nucleic Acids Res..

[12]  Gerard J. P. van Westen,et al.  Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets , 2011 .

[13]  Ping Chen,et al.  2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase in , 2006, Journal of medicinal chemistry.

[14]  Peteris Prusis,et al.  Proteochemometrics: A Tool for Modeling the Molecular Interaction Space , 2005 .

[15]  K. Fidelis,et al.  Generalized modeling of enzyme–ligand interactions using proteochemometrics and local protein substructures , 2006, Proteins.

[16]  R. Morphy Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.

[17]  P. Hajduk,et al.  Navigating the kinome. , 2011, Nature chemical biology.

[18]  Mindy I. Davis,et al.  Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.

[19]  H. Matter,et al.  Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. , 2002, Journal of medicinal chemistry.

[20]  Maurizio Vichi,et al.  Studies in Classification Data Analysis and knowledge Organization , 2011 .

[21]  L. Wodicka,et al.  A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.

[22]  Irini A. Doytchinova,et al.  EpiTOP - a proteochemometric tool for MHC class II binding prediction , 2010, Bioinform..

[23]  P. Changelian,et al.  The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. , 2008, European journal of pharmacology.

[24]  Peteris Prusis,et al.  Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions , 2005, Bioinform..

[25]  William L. Jorgensen,et al.  Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..

[26]  Didier Rognan,et al.  Enhancing the Accuracy of Chemogenomic Models with a Three-Dimensional Binding Site Kernel , 2011, J. Chem. Inf. Model..

[27]  G. Wohlfahrt,et al.  Field‐based comparison of ligand and coactivator binding sites of nuclear receptors , 2009, Biopolymers.

[28]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[29]  Mindy I. Davis,et al.  A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.

[30]  Christoph Steinbeck,et al.  Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials. , 2006, Journal of molecular graphics & modelling.

[31]  P. Prusis,et al.  Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. , 2008, Bioorganic & medicinal chemistry.

[32]  G. Scapin Protein kinase inhibition: different approaches to selective inhibitor design. , 2006, Current drug targets.

[33]  Joost C. M. Uitdehaag,et al.  A theoretical entropy score as a single value to express inhibitor selectivity , 2011, BMC Bioinformatics.

[34]  P. Bamborough System-based drug discovery within the human kinome , 2012, Expert opinion on drug discovery.

[35]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[36]  E. Casale,et al.  Through the "gatekeeper door": exploiting the active kinase conformation. , 2010, Journal of medicinal chemistry.

[37]  D. Flower,et al.  Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. , 2010, European journal of medicinal chemistry.

[38]  W. Sherman,et al.  Understanding Kinase Selectivity Through Energetic Analysis of Binding Site Waters , 2010, ChemMedChem.

[39]  Woody Sherman,et al.  Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..

[40]  T. Lundstedt,et al.  Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.

[41]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[42]  Shandar Ahmad,et al.  Proteochemometric Recognition of Stable Kinase Inhibition Complexes Using Topological Autocorrelation and Support Vector Machines , 2010, J. Chem. Inf. Model..

[43]  Weida Tong,et al.  Mold2, Molecular Descriptors from 2D Structures for Chemoinformatics and Toxicoinformatics , 2008, J. Chem. Inf. Model..

[44]  G. V. van Westen,et al.  Structure-Based Identification of OATP1B1/3 Inhibitors , 2013, Molecular Pharmacology.

[45]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[46]  J. Topliss,et al.  Chance correlations in structure-activity studies using multiple regression analysis , 1972 .

[47]  James R Kiefer,et al.  Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6. , 2010, Journal of molecular biology.

[48]  Jarl E. S. Wikberg,et al.  Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques , 2010, BMC Bioinformatics.